Techniques of early respiratory management of very low and extremely low birth weight infants

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Critical Care Medicine

Background:

• Preterm infants, especially those of very low birth weight (VLBW) and extremely low birth weight (ELBW), exhibit significant anatomic and physiologic immaturity.
• This immaturity predisposes them to mortality and adverse outcomes, including chronic lung disease of infancy (CLDI).
• Mechanical ventilation (MV), a standard treatment for pulmonary immaturity, carries risks such as barotrauma, volutrauma, pulmonary edema, infection, and inflammation.

Purpose of the Study:

• To compare, contrast, and integrate the clinical applications of mechanical ventilation (MV), nasal continuous positive airway pressure (NCPAP), and surfactant administration.
• To support the consideration of these respiratory support strategies in VLBW and ELBW infants.
• To advocate for reduced reliance on MV in favor of NCPAP.

Main Methods:

• Review and comparison of existing treatment strategies for respiratory support in preterm infants.
• Evaluation of clinical outcomes associated with MV, NCPAP, and surfactant administration.
• Integration of findings to propose an optimized approach to respiratory management.

Main Results:

• Nasal continuous positive airway pressure (NCPAP) is presented as a safe alternative to mechanical ventilation (MV) for VLBW and ELBW infants.
• Implementing NCPAP is associated with a potential reduction in the incidence and severity of chronic lung disease of infancy (CLDI).
• This approach facilitates a more individualized respiratory support strategy tailored to the specific needs of each infant.

Conclusions:

• A reduction in the use of mechanical ventilation (MV) in favor of nasal continuous positive airway pressure (NCPAP) is a safe and recommended practice for VLBW and ELBW infants.
• This shift in respiratory support strategy is likely to decrease the occurrence of chronic lung disease of infancy (CLDI).
• Prioritizing NCPAP allows for a more personalized and potentially beneficial approach to managing pulmonary immaturity in vulnerable preterm neonates.